Hepatotoxicity Signals Across Azole Antifungals: Is Isavuconazole Safer? A Pharmacovigilance Analysis of the FDA Adverse Event Reporting System (FAERS)

Cresemba (isavuconazonium sulfate) - Astellas, Basilea

https://idweek2026.eventscribe.net/fsPopup.asp?PosterID=839579&mode=posterInfo

Varshini Thiruvadi, MD; Rakshana Ravichandran, MD; Yusuf Kagzi, MD; Salman Ahsan, MD; Mohammad Alqaisieh, MD; Manasa Kandula, MD (she/her/hers); Denise Francisco, MD (she/her/hers)

Sep 6, 2026